Instead, we identified four immune states that existed in our NSCLC patients based on the inflammation marker NLR and IL-6 plasma cytokine levels; Low inflammation and IL-6 (NLRlow, IL-6low), low inflammation and high IL-6 (NLRlow, IL-6high), high inflammation and low IL-6 (NLRhigh, IL-6low), and high inflammation and high IL-6 (NLRhigh, IL-6high). The gene discussed is IL6; the disease is non-small cell lung carcinoma.